MS2 Phage Virion Delivery of Thallium Salts for Tumor Targeting
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current targeted chemotherapy methods for malignant solid tumors (MSTs) face challenges due to the ability of MST cells to remove chemotherapeutic agents via drug resistance proteins, and existing delivery systems for toxic agents often expose the entire organism to toxicity, rather than specifically targeting tumor cells.
Innovation Solution
The use of surface-modified MS2 bacteriophage virions filled with univalent thallium salts, which are resistant to removal by drug resistance proteins, for targeted delivery to MST cells, utilizing a cyclical ligand such as iRGD for receptor interaction and penetration, ensuring controlled release and reduced toxicity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If chemotherapeutic agents are delivered to tumor cells, then the destruction of malignant cells is achieved, but the toxic agents are removed from cells by drug resistance proteins reducing effectiveness
Solution Approach 1:
The patent uses bacteriophage MS2 as an intermediary carrier to deliver thallium salts to tumor cells. The phage particle protects the toxic agent during transport and enables targeted delivery through surface modification with ligands that bind to tumor cell receptors, preventing premature removal by drug resistance proteins
Solution Approach 2:
The patent changes the chemical form of the delivery system from direct chemotherapeutic agent administration to encapsulation within bacteriophage particles. This parameter change in delivery mechanism prevents the toxic agent from being recognized and removed by drug resistance protein pumps that typically extrude free chemotherapeutic molecules
2Reliability
If highly toxic chemotherapeutic agents are used to destroy tumor cells, then the destruction of malignant cells is improved, but the exposure of the entire organism to toxicity increases
Solution Approach 1:
The patent applies local quality by modifying only the surface of the bacteriophage particles with tumor-targeting ligands, while the interior maintains its toxic cargo. This localized modification enables selective accumulation at the tumor site through receptor-mediated endocytosis, concentrating the toxic effect where needed while minimizing systemic exposure
Solution Approach 2:
The bacteriophage acts as a mediator that carries the toxic thallium salts to the tumor cells. The phage particle's ability to bind specifically to tumor cell receptors ensures that the toxic agent is delivered only to the target tissue, reducing off-target toxicity to healthy organs and systems
3Reliability
If virus-like particles are used for targeted delivery, then the specificity to tumor cells is improved, but the complexity of the delivery system increases
Solution Approach 1:
The bacteriophage MS2 serves multiple functions simultaneously: it acts as a protective carrier for the toxic cargo, provides targeted delivery through surface-modified ligand-receptor interactions, and facilitates cellular uptake via endocytosis. This multi-functionality reduces the need for additional separate delivery components, simplifying the overall system despite its sophisticated mechanism
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for effective and targeted destruction of MST cells with minimal toxicity to the organism, enabling better detection and reduced thallium dosage, while avoiding skin and mucous irritation, and ensuring the thallium ions remain within the cells until their destruction.
Implementation Method 1
the virion surface is modified, thus endowing the MS2 bacteriophage particles with the ability to be sorbed on the surface (due to the ligand-receptor interactions) and then penetrate into the cytoplasm of a malignant cell
Implementation Method 2
According to X-ray structural analysis data, interacting with genomic RNA inside an MS2 phage particle, ions of univalent thallium will achieve a concentration lethal for the cell
Data Source
AI summary
A method is provided for the poly signal activation of apoptosis of malignant solid tumour cells, carried out by means of the targeted delivery of thallium salts by surface-modified MS2 phage virions, which contain a cyclic iRGD ligand that has a high affinity for the integrins avb3 and avb5 and is covalently bound with the shell and with the core, which contains genomic RNA and thallium salts. Complex, efficient, prolonged cytotoxic action is provided on focal and metastatic clusters of malignant solid tumour cells, while minimizing undesirable side effects on the healthy cells of an organism.